NDC 82249-010
Abiraterone
Abiraterone Acetate
Abiraterone is a Oral; Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Civicascript, Llc. The primary component is Abiraterone Acetate.
| Product ID | 82249-010_0ef857ee-2bfc-4d27-a417-ad58fc3a6ff6 |
| NDC | 82249-010 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Abiraterone |
| Generic Name | Abiraterone Acetate |
| Dosage Form | Tablet |
| Route of Administration | ORAL; ORAL |
| Marketing Start Date | 2018-11-23 |
| Marketing Category | ANDA / |
| Application Number | ANDA208339 |
| Labeler Name | CivicaScript, LLC |
| Substance Name | ABIRATERONE ACETATE |
| Active Ingredient Strength | 250 mg/1 |
| Pharm Classes | Cytochrome P450 17A1 Inhibitor [EPC], Cytochrome P450 17A1 Inhibitors [MoA], Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 2D6 Inhibitors [MoA] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2023-12-31 |